U.S. markets closed

ImmuPharma plc (IMM.L)

LSE - LSE Delayed Price. Currency in GBp
Add to watchlist
8.54-0.14 (-1.61%)
At close: 4:27PM BST
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in GBp

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 6/13/2021
Current
Market Cap (intraday) 5
21.37M
Enterprise Value 3
16.15M
Trailing P/E
N/A
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
134.96
Price/Book (mrq)
2.21
Enterprise Value/Revenue 3
127.49
Enterprise Value/EBITDA 7
-2.36

Trading Information

Stock Price History

Beta (5Y Monthly) 1.26
52-Week Change 3-43.54%
S&P500 52-Week Change 338.51%
52 Week High 317.26
52 Week Low 38.10
50-Day Moving Average 38.82
200-Day Moving Average 310.35

Share Statistics

Avg Vol (3 month) 3942.02k
Avg Vol (10 day) 3563.57k
Shares Outstanding 5250.22M
Implied Shares Outstanding 6N/A
Float 174.89M
% Held by Insiders 140.04%
% Held by Institutions 118.74%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in GBP.

Fiscal Year

Fiscal Year Ends Dec 31, 2020
Most Recent Quarter (mrq)Dec 31, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-4,412.70%

Management Effectiveness

Return on Assets (ttm)-41.79%
Return on Equity (ttm)-91.93%

Income Statement

Revenue (ttm)126.67k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)-2.60%
Gross Profit (ttm)126.67k
EBITDA -5.42M
Net Income Avi to Common (ttm)-6.86M
Diluted EPS (ttm)-3.40
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)5.86M
Total Cash Per Share (mrq)0.02
Total Debt (mrq)641.84k
Total Debt/Equity (mrq)6.65
Current Ratio (mrq)5.89
Book Value Per Share (mrq)0.04

Cash Flow Statement

Operating Cash Flow (ttm)-3.33M
Levered Free Cash Flow (ttm)-1.48M